Sign inJoin free

Watch / Stock Selection

'Buy' the maker of 'the world's most expensive drug'

29 Nov 20229:25

'Buy' the maker of 'the world's most expensive drug'

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Stock selection is the name of the game, according to Kyle Macintyre from Firetrail Investments with opportunities presenting locally and globally. One company that looks good to the team on fundamental terms is CSL (CSL) - the maker of the FDA's recently approved 'world's most expensive drug' to treat Hemophilia. That's not all CSL has going for it, as Kyle explains it's bread and butter business is improving and it looks reasonable on valuation grounds. Kyle is still a believer in the energy and alternative energy narrative, which is where global diversification comes into his thinking via Darling Ingredients (NSYE: DAR) which converts food waste into fuel. Kyle reckons diversification of all kinds is the 'one trick' investors can rely on to help hedge portfolio risk. Listen to the full interview for Kyle's latest market insights and for his updated view on long-term holding Qantas (QAN)

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy